Form 4: Thermo Fisher EVP Sells Shares for Tax Obligations
Insider Transaction Report
Frederick M. Lowery, Executive Vice President of Thermo Fisher Scientific Inc., disposed of common stock to cover tax liabilities.
Summary
- Frederick M. Lowery, Executive Vice President of Thermo Fisher Scientific Inc. (TMO), disposed of a total of 667.718 shares of common stock on August 28, 2025.
- These dispositions were made at a price of $489.74 per share and were identified by transaction code "F", indicating a payment of tax liability by withholding securities.
- Following these transactions, Mr. Lowery directly beneficially owns 14,367.3724 shares of common stock.
- Additionally, Mr. Lowery indirectly beneficially owns 1,174.88 shares through a 401(k) plan and 5.036 shares through a Limited Liability Company.
- Between February 29, 2025, and August 28, 2025, Mr. Lowery acquired 27.08 shares of TMO common stock under the company's 401(k) plan.
- Mr. Lowery disclaims beneficial ownership of the indirectly held securities, except to the extent of any pecuniary interest therein.
Sentiment
Score: 5
Explanation: The filing is a routine Form 4 disclosing insider transactions for tax purposes, which does not inherently convey positive or negative sentiment regarding the company's operational performance or future prospects.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This filing is a routine disclosure of an insider stock transaction and does not provide information relevant to broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: Provides transparency into executive stock ownership and routine transactions, which is a standard aspect of corporate governance and insider reporting.
Key Dates
| Date | Description |
|---|---|
| 02/29/2025 | Start date of the period during which the reporting person acquired 27.08 shares of TMO common stock under the 401(k) plan. |
| 08/28/2025 | Date of earliest transaction (disposition of common stock) and end date of the 401(k) share acquisition period. |
| 09/02/2025 | Signature date of the reporting person's attorney-in-fact for the filing. |
Recommendation
holdThe filing is a routine Form 4 disclosing the disposition of shares by an executive to cover tax liabilities, which is a common practice. It does not provide new information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the filing itself does not present a compelling reason to buy or sell.
Keywords
Thermo Fisher Scientific, TMO, Frederick M. Lowery, Form 4, Insider Transaction, Stock Sale, Executive Compensation, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.